These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

589 related items for PubMed ID: 29190834

  • 1. Ephrin-B2 reverse signaling regulates progression and lymph node metastasis of oral squamous cell carcinoma.
    Sasabe E, Tomomura A, Tomita R, Sento S, Kitamura N, Yamamoto T.
    PLoS One; 2017; 12(11):e0188965. PubMed ID: 29190834
    [Abstract] [Full Text] [Related]

  • 2. Insulin-like growth factor-independent insulin-like growth factor binding protein 3 promotes cell migration and lymph node metastasis of oral squamous cell carcinoma cells by requirement of integrin β1.
    Yen YC, Hsiao JR, Jiang SS, Chang JS, Wang SH, Shen YY, Chen CH, Chang IS, Chang JY, Chen YW.
    Oncotarget; 2015 Dec 08; 6(39):41837-55. PubMed ID: 26540630
    [Abstract] [Full Text] [Related]

  • 3. Overexpression of c-fos promotes cell invasion and migration via CD44 pathway in oral squamous cell carcinoma.
    Dong C, Ye DX, Zhang WB, Pan HY, Zhang ZY, Zhang L.
    J Oral Pathol Med; 2015 May 08; 44(5):353-60. PubMed ID: 25482572
    [Abstract] [Full Text] [Related]

  • 4. Cellular fibronectin 1 promotes VEGF-C expression, lymphangiogenesis and lymph node metastasis associated with human oral squamous cell carcinoma.
    Morita Y, Hata K, Nakanishi M, Omata T, Morita N, Yura Y, Nishimura R, Yoneda T.
    Clin Exp Metastasis; 2015 Oct 08; 32(7):739-53. PubMed ID: 26319373
    [Abstract] [Full Text] [Related]

  • 5. Cyclooxygenase-2 promotes tumor lymphangiogenesis and lymph node metastasis in oral squamous cell carcinoma.
    Morita Y, Hata K, Nakanishi M, Nishisho T, Yura Y, Yoneda T.
    Int J Oncol; 2012 Sep 08; 41(3):885-92. PubMed ID: 22735610
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Calreticulin, an endoplasmic reticulum-resident protein, is highly expressed and essential for cell proliferation and migration in oral squamous cell carcinoma.
    Chiang WF, Hwang TZ, Hour TC, Wang LH, Chiu CC, Chen HR, Wu YJ, Wang CC, Wang LF, Chien CY, Chen JH, Hsu CT, Chen JY.
    Oral Oncol; 2013 Jun 08; 49(6):534-41. PubMed ID: 23375593
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Overexpression of caldesmon is associated with lymph node metastasis and poorer prognosis in patients with oral cavity squamous cell carcinoma.
    Chang KP, Wang CL, Kao HK, Liang Y, Liu SC, Huang LL, Hseuh C, Hsieh YJ, Chien KY, Chang YS, Yu JS, Chi LM.
    Cancer; 2013 Nov 15; 119(22):4003-11. PubMed ID: 23963810
    [Abstract] [Full Text] [Related]

  • 11. Overexpression of angiopoietin 2 promotes the formation of oral squamous cell carcinoma by increasing epithelial-mesenchymal transition-induced angiogenesis.
    Li C, Li Q, Cai Y, He Y, Lan X, Wang W, Liu J, Wang S, Zhu G, Fan J, Zhou Y, Sun R.
    Cancer Gene Ther; 2016 Sep 15; 23(9):295-302. PubMed ID: 27492854
    [Abstract] [Full Text] [Related]

  • 12. Expression and prognostic significance of EFNB2 and EphB4 genes in patients with oesophageal squamous cell carcinoma.
    Tachibana M, Tonomoto Y, Hyakudomi R, Hyakudomi M, Hattori S, Ueda S, Kinugasa S, Yoshimura H.
    Dig Liver Dis; 2007 Aug 15; 39(8):725-32. PubMed ID: 17611172
    [Abstract] [Full Text] [Related]

  • 13. Tumour cell-derived WNT5B modulates in vitro lymphangiogenesis via induction of partial endothelial-mesenchymal transition of lymphatic endothelial cells.
    Wang SH, Chang JS, Hsiao JR, Yen YC, Jiang SS, Liu SH, Chen YL, Shen YY, Chang JY, Chen YW.
    Oncogene; 2017 Mar 15; 36(11):1503-1515. PubMed ID: 27593938
    [Abstract] [Full Text] [Related]

  • 14. Receptor tyrosine kinase, RON, promotes tumor progression by regulating EMT and the MAPK signaling pathway in human oral squamous cell carcinoma.
    Kim SA, Lee KH, Lee DH, Lee JK, Lim SC, Joo YE, Chung IJ, Noh MG, Yoon TM.
    Int J Oncol; 2019 Aug 15; 55(2):513-526. PubMed ID: 31268163
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. IFIT1 and IFIT3 promote oral squamous cell carcinoma metastasis and contribute to the anti-tumor effect of gefitinib via enhancing p-EGFR recycling.
    Pidugu VK, Wu MM, Yen AH, Pidugu HB, Chang KW, Liu CJ, Lee TC.
    Oncogene; 2019 Apr 15; 38(17):3232-3247. PubMed ID: 30626937
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.